WNT1 and neoplasm: To facilitate effective identification of compounds that selectively repress WNT1 activity, we established a screening strategy that was adopted and modified from the NCI-60 Human Tumor Cell Lines Screen (https://dtp.cancer.gov/discovery_development/nci-60/methodology.htm).